146 related articles for article (PubMed ID: 29177815)
1. A Database Cohort Study to Assess the Risk of Angioedema Among Patients with Heart Failure Initiating Angiotensin-Converting Enzyme Inhibitors in the USA.
Do TP; Seetasith A; Belleli R; Schlienger RG; Corda S; Burudpakdee C; Streefkerk HJ; Behr S
Am J Cardiovasc Drugs; 2018 Jun; 18(3):205-211. PubMed ID: 29177815
[TBL] [Abstract][Full Text] [Related]
2. Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink.
Mahmoudpour SH; Baranova EV; Souverein PC; Asselbergs FW; de Boer A; Maitland-van der Zee AH;
Br J Clin Pharmacol; 2016 Dec; 82(6):1647-1659. PubMed ID: 27524468
[TBL] [Abstract][Full Text] [Related]
3. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
[TBL] [Abstract][Full Text] [Related]
4. Angioedema Among Hypertensive Patients Treated with Aliskiren or Other Antihypertensive Medications in the United States.
Schlienger RG; Korn JR; Wehler E; Lopez Leon S; Yeaw J
Am J Cardiovasc Drugs; 2017 Dec; 17(6):465-474. PubMed ID: 28779444
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive drug associated angioedema: effect modification by race/ethnicity.
Reichman ME; Wernecke M; Graham DJ; Liao J; Yap J; Chillarige Y; Southworth MR; Keeton S; Goulding MR; Mott K; Kelman JA
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1190-1196. PubMed ID: 28722207
[TBL] [Abstract][Full Text] [Related]
6. Angioedema and angiotensin-converting enzyme inhibitors: are demographics a risk?
Mahoney EJ; Devaiah AK
Otolaryngol Head Neck Surg; 2008 Jul; 139(1):105-8. PubMed ID: 18585570
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of ACE Inhibitor Angioedema Utilizing a Large Electronic Health Record.
Banerji A; Blumenthal KG; Lai KH; Zhou L
J Allergy Clin Immunol Pract; 2017; 5(3):744-749. PubMed ID: 28377081
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II receptor blockers are safe in patients with prior angioedema related to angiotensin-converting enzyme inhibitors - a nationwide registry-based cohort study.
Rasmussen ER; Pottegård A; Bygum A; von Buchwald C; Homøe P; Hallas J
J Intern Med; 2019 May; 285(5):553-561. PubMed ID: 30618189
[TBL] [Abstract][Full Text] [Related]
9. Lower Hospitalization and Healthcare Costs With Sacubitril/Valsartan Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin-Receptor Blocker in a Retrospective Analysis of Patients With Heart Failure.
Albert NM; Swindle JP; Buysman EK; Chang C
J Am Heart Assoc; 2019 May; 8(9):e011089. PubMed ID: 31023122
[TBL] [Abstract][Full Text] [Related]
10. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
Fang G; Annis IE; Farley JF; Mahendraratnam N; Hickson RP; Stürmer T; Robinson JG
Pharmacotherapy; 2018 Jan; 38(1):29-41. PubMed ID: 29059475
[TBL] [Abstract][Full Text] [Related]
11. Different patterns of angioedema in patients with and without angiotensin-converting enzyme inhibitor therapy.
Herkner H; Temmel AF; Müllner M; Havel C; Hirschl MM; Kofler J; Laggner AN
Wien Klin Wochenschr; 2001 Mar; 113(5-6):167-71. PubMed ID: 11293945
[TBL] [Abstract][Full Text] [Related]
12. Addition of angiotensin-converting enzyme inhibitors to beta-blockers has a distinct effect on hispanics compared with african americans and whites with heart failure and reduced ejection fraction: a propensity score-matching study.
Eshtehardi P; Pamerla M; Mojadidi MK; Goodman-Meza D; Hovnanians N; Gupta A; Lupercio F; Mazurek JA; Zolty R
J Card Fail; 2015 Jun; 21(6):448-56. PubMed ID: 25805065
[TBL] [Abstract][Full Text] [Related]
13. Physician adjudication of angioedema diagnosis codes in a population of patients with heart failure prescribed angiotensin-converting enzyme inhibitor therapy.
Mansi ET; Johnson ES; Thorp ML; Go AS; Lee MS; Shen AY; Park KJ; Budzynska K; Markin A; Sung SH; Thompson JH; Slaughter MT; Luong TQ; An J; Reynolds K; Roblin DW; Cassidy-Bushrow AE; Kuntz JL; Schlienger RG; Behr S; Smith DH
Pharmacoepidemiol Drug Saf; 2021 Dec; 30(12):1630-1634. PubMed ID: 34558760
[TBL] [Abstract][Full Text] [Related]
14. Brief review: angiotensin converting enzyme inhibitors and angioedema: anesthetic implications.
Sarkar P; Nicholson G; Hall G
Can J Anaesth; 2006 Oct; 53(10):994-1003. PubMed ID: 16987854
[TBL] [Abstract][Full Text] [Related]
15. Life-threatening orolingual angioedema during thrombolysis in acute ischemic stroke.
Engelter ST; Fluri F; Buitrago-Téllez C; Marsch S; Steck AJ; Rüegg S; Lyrer PA
J Neurol; 2005 Oct; 252(10):1167-70. PubMed ID: 16184341
[TBL] [Abstract][Full Text] [Related]
16. Exome Sequencing Reveals Common and Rare Variants in F5 Associated With ACE Inhibitor and Angiotensin Receptor Blocker-Induced Angioedema.
Maroteau C; Siddiqui MK; Veluchamy A; Carr F; White M; Cassidy AJ; Baranova EV; Rasmussen ER; Eriksson N; Bloch KM; Brown NJ; Bygum A; Hallberg P; Karawajczyk M; Magnusson PKE; Yue QY; Syvänen AC; von Buchwald C; Alfirevic A; Maitland-van der Zee AH; Wadelius M; Palmer CNA;
Clin Pharmacol Ther; 2020 Dec; 108(6):1195-1202. PubMed ID: 32496628
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibitor-induced angioedema: A review of the literature.
Brown T; Gonzalez J; Monteleone C
J Clin Hypertens (Greenwich); 2017 Dec; 19(12):1377-1382. PubMed ID: 28994183
[TBL] [Abstract][Full Text] [Related]
18. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
Lee J; Lee S
Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
[TBL] [Abstract][Full Text] [Related]
19. Do ACE Inhibitors/Angiotensin II type 1 receptor antagonists reduce hospitalisations in older patients with heart failure? A propensity analysis.
Trewet CB; Shireman TI; Rigler SK; Howard PA
Drugs Aging; 2007; 24(11):945-55. PubMed ID: 17953461
[TBL] [Abstract][Full Text] [Related]
20. Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors.
Miller DR; Oliveria SA; Berlowitz DR; Fincke BG; Stang P; Lillienfeld DE
Hypertension; 2008 Jun; 51(6):1624-30. PubMed ID: 18413488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
